Treatment Thresholds For Intervention in Posthaemorrhagic Ventricular Dilation: A Randomised Controlled Trial
Treatment Thresholds For Intervention in Posthaemorrhagic Ventricular Dilation: A Randomised Controlled Trial
com
ADC-FNN Online First, published on February 10, 2018 as 10.1136/archdischild-2017-314206
Original article
Original article
are the anterior horn width (AHW) and thalamo-occipital and/or the TOD was >25 mm (figure 1). Intervention started
distance (TOD).16 17 with LPs (max 3), and if necessary, followed by insertion and
In previous retrospective studies, very early intervention, taps from a VR, aiming for VI<p97 over the next 7–10 days. Ten
prior to development of clinical symptoms and prior to severe mL/kg were removed once or twice a day, the volume adjusted
dilatation of the lateral ventricles, was associated with a reduced according to cUS. When taps from a VR were still needed 28
need for a ventriculoperitoneal (VP) shunt and better neurode- days after insertion to keep the VI well below the p97+4 mm,
velopmental outcome.2 3 18 one or two ‘challenges’ were performed with discontinuation of
Our aim was to test the hypothesis that very early interven- taps. Reservoir taps were resumed in case of expanding ventri-
tion, before crossing the p97+4 mm line, reduces death and/or cles, clinical symptoms and/or excessive head growth. Taps
the need for VP shunt when compared with later intervention. were continued until infant's weight reached 2000–2500 g and
according to unit protocol, the protein had decreased to <1.5 g/L
Patients and methods and erythrocytes <100/mm3, at which stage the infant became
Study infants eligible for a VP shunt.
Enrolled infants were born between July 2006 and July 2016
and admitted to eight neonatal intensive care units in the Neth- High threshold
erlands, five centres in Europe and one in the USA. Inclusion Treatment was started once the VI had crossed the p97+4 mm
criteria: (1) preterm infants (gestational age (GA)≤34 weeks) line and the AHW was >10 mm. Further treatment was compa-
with a grade III or IV haemorrhage diagnosed with cUS; (2) <28 rable to the early treatment arm (figure 2).
days after birth; (3) progressive dilatation of both lateral ventri-
cles with ventricular width >p97 and AHW >6 mm. Exclusion Shunt surgery
criteria: (1) chromosomal disorders; (2) congenital malforma- Adequate weight, cerebrospinal fluid (CSF) protein and eryth-
tions; (3) cystic periventricular leukomalacia; (4) infection of the rocytes being achieved, reservoir punctures were discontinued
central nervous system prior to randomisation. and VI/AHW, head circumference measurements and clinical
symptoms reviewed daily. If the local team observed continued
Cranial ultrasound ventricular expansion and accelerated head enlargement, a
Serial cUS was performed at least twice a week following the VP shunt was indicated, with symptoms increasing the urgency.
diagnosis of a grade III/IV haemorrhage to diagnose PHVD and An external review was performed later for infants who under-
follow progression. Ventricular measurements, VI/AHW and went shunt surgery. PG and LSdV reviewed the VI and AHW
TOD were performed on all ultrasound scans and plotted on graphs, the head circumference graphs and the cUS images for
the Levene and Davies graphs.12 16 Measurements were recorded infants shunted but not born in their own centres to confirm
following informed consent, at randomisation, before each that shunt criteria were met. They were blind to the treatment
lumber puncture (LP), 1, 2 and 3 weeks after the first LP, before allocation. These external reviews agreed with the local shunt
ventricular reservoir (VR) insertion and weekly till stabilisation, decision in all cases.
discharge or VP shunt placement.
Outcomes
Treatment Primary outcome was a composite of VP shunt placement and/
Low threshold or death. Diagnosis of VR dysfunction, infection and revi-
Treatment was started after the VI had crossed p97 but before sion or need for a second reservoir were recorded as well
crossing the p97+4 mm line, the AHW was >6 mm but <10 mm as VP shunt dysfunction, infection and need for revision.
Figure 1 Example of early intervention, gestational age 26 weeks/birth weight 925 g; three lumbar punctures (LPs) were performed when the
ventricular index had crossed the p97 (2SD) and was heading towards the p97+4 mm line. No further intervention was required. The first MRI (A,
coronal T2-weighted sequence) was performed after the three LPs at 30 weeks postmenstrual age and the second MRI (B) at term equivalent age,
showing remnants of the intraventricular haemorrhage and nearly normal size and shape of the lateral ventricles. VP, ventriculoperitoneal.
F2 de Vries LS, et al. Arch Dis Child Fetal Neonatal Ed 2018;0:F1–F6. doi:10.1136/archdischild-2017-314206
Downloaded from http://fn.bmj.com/ on February 10, 2018 - Published by group.bmj.com
Original article
Figure 2 Example of later intervention, gestational age 33+6 weeks/birth weight 1790 g; three lumbar punctures (LPs) were performed once the
ventricular index had crossed the p97+4 mm line and a ventricular reservoir was subsequently inserted. The ventricular index came down to below
the p97 line with daily taps from the -ventricular reservoir, which could be stopped after 19 days. No further intervention was required. The coronal
ultrasound (A) performed before the first LP shows intraventricular clots and ballooning shape of the lateral ventricles. The coronal MRI (T1-weighted
image) at term equivalent age (B) shows mild ventricular dilatation. VP, ventriculoperitoneal.
Neurodevelopmental outcome at 2 years corrected age will be decrease in the adverse outcome with 45%–22% with a power
reported separately. of 80%.
Written informed consent was obtained from both parents of
Randomisation and statistical analysis each infant.
Computer-generated randomisation was used online to allocate
infants to treatment groups in a 1:1 ratio. Randomisation was
stratified by centre and in blocks of 5. Analysis was by intention Results
to treat. Recruitment started in the Netherlands in July 2006 and ended
Based on previous trials, inclusion criteria predicted that 60% in July 2016. Due to slow enrolment, additional centres were
of the infants would die or need a VP shunt. Our initial power invited to participate, Bristol 2007, St Louis 2009, Lund 2010,
calculation (using a 5% level of significance) indicated that 50 Cadiz, Barcelona and Lisbon 2013. A total of 126 infants were
infants in each group would give 87% power of detecting a recruited. Most infants were recruited in Bristol (29), Utrecht
reduction from 60% in primary outcome to 30%. During the (23), Nijmegen (23), Zwolle (12), Cadiz (12), while between 2
trial, the incidence of an adverse outcome was found to be much and 6 infants were enrolled in the other nine centres.
lower (around 45%) than the expected adverse outcome of The two treatment groups were comparable for sex, gesta-
60%. Therefore, a new power calculation was done, indicating tional age and birth weight as well as having a grade III or IV
a sample size of 63 patients per study arm, to demonstrate a haemorrhage and day of randomisation (table 1).
de Vries LS, et al. Arch Dis Child Fetal Neonatal Ed 2018;0:F1–F6. doi:10.1136/archdischild-2017-314206 F3
Downloaded from http://fn.bmj.com/ on February 10, 2018 - Published by group.bmj.com
Original article
aureus and Klebsiella pneumoniae occurred in two other infants,
both were treated with antibiotics without removal of the VR.
Nine infants died (14%), four without any intervention (two
sepsis, one NEC, one acute respiratory failure), three following
LPs (one sepsis, one BPD, one meningitis following discharge
home) and two following insertion of a VR (one candida sepsis,
one NEC). Fourteen infants required a VP shunt (23%), seven
following a grade III and seven following a grade IV haemor-
rhage. One infant needed a revision following an infection, one
had a disconnection but the VP shunt was not revised and in one
infant a second fenestration was performed.
Original article
Figure 4 Median maximum ventricular measurements, including ventricular index in mm above the +2 SD line on the Y-axis on the left (panel A)
and anterior horn width (AHW) in mm above the 6 mm line on the Y-axis on the right (panel B), for the infants in the low (LT) and the high threshold
(HT) group depicted on the X-axis. Median maximum ventricular index measurements (mm >2SD) were 2.8 mm in the early group compared with
4.2 mm in the later intervention group (P<0.001). Median maximum measurements of the anterior horn width (mm >6 mm) were 3.0 mm in the early
and 5.0 mm in the later intervention group (P<0.001).
second half of the study period (10/19 and 5/33, respectively observational cohort study, as many as 92% of preterm infants
(P=0.01)). There was no significant difference in GA or birth required a shunt when treatment was started following onset
weight for infants with and without complications. of clinical symptoms.20
Enrolment in the present study was much slower than
Discussion expected, as fewer infants developed a severe GMH-IVH.
We were unable to show a further reduction in the need for Compliance with trial management was generally good, but
a VP shunt in the LT group, but the need for VP shunt place- interpretation of the protocol was inappropriate in about 10%
ment in both study groups is, to the best of our knowledge, of the cases but following intention to treat, these infants were
the lowest reported so far. In the HT group, the number of included in the analysis.
infants who had LPs and VRs was significantly lower than in The rate of infection for the different intervention methods
the LT group. Whether this increase in additional interven- was low. CNS infection did not occur following LPs and in
tions in the LT group will be associated with improved pres- only 6% of the infants following VR insertion, similar to a
ervation of brain volumes and improved neurodevelopmental previous single-centre study.21 A second VR was required in
outcome still needs to be determined. Intervention can be about 15% of the infants, mostly due to dysfunction. Both
considered early in both groups, when compared with timing types of complications may further increase the risk of an
of intervention in previous studies. In the first randomised adverse outcome. Infection is known to have an adverse
controlled trial (RCT) performed, the VentriculoMegaly effect on outcome, even when there is no evidence that the
trial, there was no upper limit on VI at entry and only LPs or CNS is involved.22 Complications were less common during
ventricular taps were performed. These methods were only the second half of the study period, suggestive of a learning
used to prevent further dilatation, but not to bring the VI curve. Recently, more attention has been given to the risk
down to within the normal range.13 There was no significant of anaesthesia in young children and this may be especially
difference between the number of infants VP shunted between important in extremely preterm infants.23 24 The proportion
the two groups (53% and 54%). The next RCT, using acet- of VR and VP shunts with dysfunction needing revision was
azolamide and furosemide, also had no upper limit on VI at higher in the LT group than the HT group. Even though, in
entry. Seven per cent had a VR inserted in the arm receiving most centres, insertion of a VP shunt was only performed
drugs and 14% in the standard arm.14 The number of infants when the infant had reached a weight of 2–2.5 kg and the
VP shunted was significantly higher in the treatment group protein and red cell count were low, the need for revision was
(51%) compared with the standard treatment group (38%) high (25%), which was due to disconnection or dysfunction
and the composite outcome (death and/or shunt) was signifi- in most cases. Each need for revision, involved a period of
cantly worse in the treatment arm as well. The DRIFT increased intracranial pressure and the need for anaesthesia.
(drainage, irrigation and fibrinolytic therapy) trial also had Every revision is associated with a small reduction in IQ
no upper limit on VI at entry. Thirty-eight per cent in the points.25
DRIFT arm had VR insertion and 75% in the standard group. In the DRIFT trial, there was no significant reduction in the
Once again, there was no significant difference between the need for a VP shunt, but a subsequent improvement in neuro-
number of infants VP shunted between the two groups (38% developmental outcome at 2 years corrected age was noted
and 39%). A recent prospective cohort study from the Hydro- in the DRIFT arm.26 In the current trial, we will determine
cephalus Clinical Research Network reported that 56% of whether the increased number of (neurosurgical) interventions
those treated when the frontal-occipital horn ratio exceeded needed in the early study arm influences neurodevelopmental
0.55 with clinical symptoms were VP shunted.19 In a recent outcome.
de Vries LS, et al. Arch Dis Child Fetal Neonatal Ed 2018;0:F1–F6. doi:10.1136/archdischild-2017-314206 F5
Downloaded from http://fn.bmj.com/ on February 10, 2018 - Published by group.bmj.com
Original article
Conclusions References
Control of PHVD, using LPs and taps from a VR before or just 1 Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and
intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.
after the VI crossed the p97+4 mm line was associated with the
J Pediatr 1978;92:529–34.
lowest need for VP shunt reported so far. No significant reduc- 2 de Vries LS, Liem KD, van Dijk K, et al. Early versus late treatment of posthaemorrhagic
tion in VP shunt insertion and no difference in mortality was ventricular dilatation: results of a retrospective study from five neonatal intensive care
found following very early as compared with later intervention units in The Netherlands. Acta Paediatr 2002;91:212–7.
for PHVD but intervention at p97+4 mm involved fewer LPs 3 Brouwer A, Groenendaal F, van Haastert IL, et al. Neurodevelopmental outcome of
preterm infants with severe intraventricular hemorrhage and therapy for post-
and reservoir insertions. hemorrhagic ventricular dilatation. J Pediatr 2008;152:648–54.
4 Ahn SY, Shim SY, Sung IK. Intraventricular hemorrhage and post hemorrhagic
Author affiliations hydrocephalus among very-low-birth-weight infants in Korea. J Korean Med Sci
1
Department of Neonatology and Brain Center Rudolf Magnus, Wilhelmina Children’s 2015;30(Suppl 1):S52–8.
Hospital, University Medical Center Utrecht, Utrecht, The Netherlands 5 Ingram MC, Huguenard AL, Miller BA, et al. Poor correlation between head
2
Department of Neonatology, Amalia Children’s Hospital, Radboud University circumference and cranial ultrasound findings in premature infants with
Medical Center, Nijmegen, The Netherlands intraventricular hemorrhage. J Neurosurg Pediatr 2014;14:184–9.
3
Department of Neonatology, Southmead Hospital, School of Clinical Science, 6 De Vries LS, Pierrat V, Minami T, et al. The role of short latency somatosensory evoked
University of Bristol, Bristol, UK responses in infants with rapidly progressive ventricular dilatation. Neuropediatrics
4
University of Applied Sciences Utrecht, Utrecht, The Netherlands 1990;21:136–9.
5
Department of Neonatology, Erasmus Medical Center, Rotterdam, The Netherlands 7 Klebermass-Schrehof K, Rona Z, Waldhör T, et al. Can neurophysiological assessment
6
Neonatology Department, ’Puerta del Mar’ University Hospital, Cadiz, Spain improve timing of intervention in posthaemorrhagic ventricular dilatation? Arch Dis
7
Isala Women and Children’s Hospital, Zwolle, The Netherlands Child Fetal Neonatal Ed 2013;98:F291–F297.
8
Department of Neonatology, Leiden University Medical Center, Leiden, The 8 van Alfen-van der Velden AA, Hopman JC, Klaessens JH, et al. Cerebral hemodynamics
Netherlands and oxygenation after serial CSF drainage in infants with PHVD. Brain Dev
9
Directorate Quality & Patientcare, Erasmus Medical Center, University Medical 2007;29:623–9.
Center Rotterdam, Rotterdam, The Netherlands 9 Norooz F, Urlesberger B, Giordano V, et al. Decompressing posthaemorrhagic
10 ventricular dilatation significantly improves regional cerebral oxygen saturation in
Division of Neuroscience, Department of Neurosurgery, University Medical Center
Utrecht, Utrecht, The Netherlands preterm infants. Acta Paediatr 2015;104:663–9.
10 Olischar M, Klebermass K, Hengl B, et al. Cerebrospinal fluid drainage in
posthaemorrhagic ventricular dilatation leads to improvement in amplitude-integrated
Collaborators The ELVIS study group: Han K; Division of Neuroscience,
electroencephalographic activity. Acta Paediatr 2009;98:1002–9.
Department of Neurosurgery, University Medical Centre, The Netherlands,
11 Kochan M, McPadden J, Bass WT, et al. Changes in cerebral oxygenation in preterm
Steggerda S; Department of Neonatology, Leiden University Medical Center,
infants with progressive posthemorrhagic ventricular dilatation. Pediatr Neurol
Leiden, The Netherlands, Benders MJNL; Department of Neonatology and Brain
2017;73:57–63.
Center Rudolf Magnus, Wilhelmina Children’s Hospital, University Medical Center
12 Levene MI. Measurement of the growth of the lateral ventricles in preterm infants
Utrecht, Utrecht, The Netherlands, Dudink J; Department of Neonatology and
with real-time ultrasound. Arch Dis Child 1981;56:900–4.
Brain Center Rudolf Magnus, Wilhelmina Children’s Hospital, University Medical
13 Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation.
Center Utrecht, Utrecht, The Netherlands; ter Horst HJ; Department Neonatology,
Ventriculomegaly trial group. Arch Dis Child 1990;65(1 Spec No):3–10.
UMCG, Groningen, The Netherlands, Dijkman KP; Department Neonatology,
14 International randomised controlled trial of acetazolamide and furosemide in
Máxima Medical Center, Veldhoven, The Netherlands, Ley D; Department posthaemorrhagic ventricular dilatation in infancy. International PHVD drug trial
Pediatrics, Institute of Clinical Sciences, Lund, Sweden, Fellman V; Department group. Lancet 1998;352:433–40.
Pediatrics, Institute of Clinical Sciences, Lund, Sweden, de Haan TR; Department 15 Whitelaw A, Evans D, Carter M, et al. Randomized clinical trial of prevention of
Neonatology, Emma Children’s Hospital, Academic Medical Center, University of hydrocephalus after intraventricular hemorrhage in preterm infants: brain-washing
Amsterdam, The Netherlands, Agut Quijano T; Department Neonatology, Hospital versus tapping fluid. Pediatrics 2007;119:e1071–e1078.
Sant Joan de Deu, Barcelona, Spain, Barcik U; Department Neonatology, Hospital 16 Davies MW, Swaminathan M, Chuang SL, et al. Reference ranges for the linear
Sant Joan de Deu, Barcelona, Spain, Mathur A; Division of Newborn Medicine, dimensions of the intracranial ventricles in preterm neonates. Arch Dis Child Fetal
Edward Mallinckrodt Department of Pediatrics, Washington University School of Neonatal Ed 2000;82:218F–23.
Medicine, St Louis, USA, Graca AM; Department Neonatology, Hospital de Santa 17 Brouwer MJ, de Vries LS, Groenendaal F, et al. New reference values for the neonatal
Maria, Lisbon, Portugal. cerebral ventricles. Radiology 2012;262:224–33.
Contributors All authors and partners of the ELVIS study group. Enrolled patients 18 Bassan H, Eshel R, Golan I, et al. Timing of external ventricular drainage
in one of the 14 participating centres. Entered clinical data in the Electronic and neurodevelopmental outcome in preterm infants with posthemorrhagic
database. Had substantial contributions to the conception or design of the work, hydrocephalus. Eur J Paediatr Neurol 2012;16:662–70.
or the acquisition, analysis or interpretation of data. Drafting the work or revising it 19 Wellons JC, Shannon CN, Holubkov R, et alShunting outcomes in posthemorrhagic
critically for important intellectual content. Final approval of the version published. hydrocephalus: results of a hydrocephalus clinical research network prospective
Agreement to be accountable for all aspects of the work in ensuring that questions cohort studyJ Neurosurg Pediatr 2017;20:19–29.
related to the accuracy or integrity of any part of the work are appropriately 20 Leijser LM, Miller SP, van Wezel-Meijler G, et al. Posthemorrhagic ventricular dilatation
investigated and resolved. in preterm infants. Neurology. 2018. In Press.
21 Brouwer AJ, Groenendaal F, van den Hoogen A, et al. Incidence of infections of
Competing interests None declared. ventricular reservoirs in the treatment of post-haemorrhagic ventricular dilatation: a
Patient consent Parental/guardian consent obtained. retrospective study (1992-2003). Arch Dis Child Fetal Neonatal Ed 2007;92:F41–F43.
22 Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth
Ethics approval The study (ISRCTN43171322) was approved by the Medical
impairment among extremely low-birth-weight infants with neonatal infection. JAMA
Ethics Board Erasmus Medical Center Rotterdam.
2004;292:2357–65.
Provenance and peer review Not commissioned; externally peer reviewed. 23 Andropoulos DB, Greene MF. Anesthesia and developing brains - implications of the
FDA warning. N Engl J Med 2017;376:905–7.
Data sharing statement Eight of 126 infants are also included in another paper.
24 Filan PM, Hunt RW, Anderson PJ, et al. Neurologic outcomes in very preterm infants
This is an observational study about posthaemorrhagic ventricular dilation, which is
undergoing surgery. J Pediatr 2012;160:409–14.
a present in press for Neurology. These data can be accessed when needed from the
25 Arrington CN, Ware AL, Ahmed Y, et al. Are shunt revisions associated with iq in
first author.
congenital hydrocephalus? A meta -analysis. Neuropsychol Rev 2016;26:329–39.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 26 Whitelaw A, Jary S, Kmita G, et al. Randomized trial of drainage, irrigation and
article) 2018. All rights reserved. No commercial use is permitted unless otherwise fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation:
expressly granted. developmental outcome at 2 years. Pediatrics 2010;125:e852–e858.
F6 de Vries LS, et al. Arch Dis Child Fetal Neonatal Ed 2018;0:F1–F6. doi:10.1136/archdischild-2017-314206
Downloaded from http://fn.bmj.com/ on February 10, 2018 - Published by group.bmj.com
Arch Dis Child Fetal Neonatal Ed published online February 10, 2018
These include:
References This article cites 25 articles, 7 of which you can access for free at:
http://fn.bmj.com/content/early/2018/02/10/archdischild-2017-314206
#ref-list-1
Email alerting Receive free email alerts when new articles cite this article. Sign up in the
service box at the top right corner of the online article.
Notes